top of page

Partial Rebreathing Ineffective for Migraine Aura Relief
A recent study published in the journal Headache explored the efficacy of a partial rebreathing device for treating migraine with aura. The device aim...

MigraineMind
Nov 23, 20251 min read
Atogepant: Reducing Migraine Days in Episodic and Chronic Cases
A recent study published in CPT Pharmacometrics & Systems Pharmacology explored the exposure-response relationship of atogepant for preventing migrain...

MigraineMind
Nov 23, 20251 min read
Eptinezumab: Effective Long-Term Relief for Chronic Migraines
A recent study published in the Journal of Headache and Pain investigates the long-term use of eptinezumab, a treatment for chronic migraine, in Japan...

MigraineMind
Nov 23, 20251 min read
New Polysaccharide in TCM Shows Promise for Migraine Relief
A recent study published in Carbohydrate Polymers delves into the structural and pharmacokinetic properties of Tianshu Capsule (TSC), a traditional Ch...

MigraineMind
Nov 23, 20251 min read
Daily Research Roundup: 4 New Migraine Studies
Today's migraine research brings 4 important studies covering breakthrough treatments, new insights, and innovative approaches to migraine management....

MigraineMind
Nov 23, 20251 min read
Partial Rebreathing Device Ineffective for Migraine Aura Relief
A recent study published in Headache explored the potential of a partial rebreathing device for early treatment of migraine with aura. The study aimed...

MigraineMind
Nov 23, 20251 min read
Atogepant's Impact on Reducing Monthly Migraine Days Analyzed
A recent study published in CPT Pharmacometrics & Systems Pharmacology explored the exposure-response relationship of atogepant for reducing monthly m...

MigraineMind
Nov 23, 20251 min read
bottom of page